Filing Details
- Accession Number:
- 0001179110-13-003099
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-02-20 16:52:54
- Reporting Period:
- 2013-02-17
- Filing Date:
- 2013-02-20
- Accepted Time:
- 2013-02-20 16:52:54
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
916085 | Health Net Inc | HNT | Hospital & Medical Service Plans (6324) | 954288333 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1213947 | James Woys | 21650 Oxnard Street Woodland Hills CA 91367 | Evp, Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2013-02-17 | 2,635 | $27.43 | 218,312 | No | 4 | F | Direct | |
Common Stock | Disposition | 2013-02-18 | 5,637 | $27.43 | 212,675 | No | 4 | F | Direct | |
Common Stock | Acquisiton | 2013-02-19 | 60,000 | $24.06 | 272,675 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-02-19 | 53,912 | $26.76 | 218,763 | No | 4 | S | Direct | |
Common Stock | Disposition | 2013-02-19 | 2,272 | $27.07 | 216,491 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | F | Direct | |
No | 4 | F | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Acquisiton | 2013-02-19 | 60,000 | $0.00 | 60,000 | $24.06 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2004-02-20 | 2013-02-20 | No | 4 | M | Direct |
Footnotes
- Shares forfeited in lieu of payment of tax liability in connection with the vesting of 33-1/3% of a grant of 21,250 restricted stock units ("RSUs") made to the Reporting Person on February 17, 2012, pursuant to the Issuer's 2006 Long-Term Incentive Plan, as amended (the "2006 Plan").
- The number of shares forfeited by the Reporting Person was based on the closing price of the Issuer's common stock on February 15, 2013, pursuant to the terms of the 2006 Plan.
- Shares forfeited in lieu of payment of tax liability in connection with the vesting of 33-1/3% of a grant of 45,000 RSUs made to the Reporting Person on February 18, 2011, pursuant to the terms of the 2006 Plan.
- The number of shares forfeited by the Reporting Person was based on the closing price of the Issuer's common stock on February 15, 2013, pursuant to the terms of the 2006 Plan.
- Exercise of a Stock Option (Right to Buy) granted to the Reporting Person on February 20, 2003 under the Issuer's 1997 Stock Option Plan, as amended (the "2003 Grant"), in a transaction exempt under Rule 16b-3 of the Securities Exchange Act of 1934, as amended (the "Act"). The exercise of the 2003 Grant was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.98 to $26.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person on February 19, 2013, as reported on this Form 4, were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.99 to $27.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person on February 19, 2013, as reported on this Form 4, were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
- Includes 5,450 shares in which the Reporting Person has a beneficial interest under the profit-sharing component of the Issuer's 401(k) Savings Plan.
- The stock option became exercisable in 25% increments on each of the first, second, third and fourth anniversaries of the grant date.
- Represents unexercised options from the 2003 Grant to the Reporting Person beneficially owned by the Reporting Person.